MARKET

XTLB

XTLB

Xtl Biopharmaceu
NASDAQ
2.963
+0.273
+10.16%
After Hours: 2.660 -0.303 -10.24% 19:37 07/24 EDT
OPEN
2.710
PREV CLOSE
2.690
HIGH
3.040
LOW
2.710
VOLUME
81.34K
TURNOVER
0
52 WEEK HIGH
4.990
52 WEEK LOW
0.7500
MARKET CAP
16.15M
P/E (TTM)
-9.0621
1D
5D
1M
3M
1Y
5Y
1D
XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes
TipRanks · 2d ago
Weekly Report: what happened at XTLB last week (0715-0719)?
Weekly Report · 3d ago
Weekly Report: what happened at XTLB last week (0708-0712)?
Weekly Report · 07/15 09:32
Weekly Report: what happened at XTLB last week (0701-0705)?
Weekly Report · 07/08 09:32
Weekly Report: what happened at XTLB last week (0624-0628)?
Weekly Report · 07/01 09:32
Weekly Report: what happened at XTLB last week (0617-0621)?
Weekly Report · 06/24 09:34
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ovid Therapeutics Inc dipped 65.7% after Takeda’s Skyline study in Dravet syndrome missed its primary endpoint. Interactive Strength Inc. Shares climbed 148% to $7.07 after dipping 19% on Friday. Mustang Bio, Inc. (NASDAQ:MBIO) shares jumped 145% after the company announced safety and efficacy data.
Benzinga · 06/17 17:21
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Nurix Therapeutics, Inc. Rose sharply in today's pre-market trading. The company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory chronic lymphocytic leukemia. Nurix shares jumped 12.1% to $17.01 in the pre-markets trading session. Scinai Immunotherapeutics Ltd. And The Aaron's Company were among the stocks moving in pre- market trading.
Benzinga · 06/17 12:43
More
About XTLB
XTL Biopharmaceuticals Ltd is an Israel-based biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

Webull offers X T L Biopharmaceuticals Ltd (ADR) stock information, including NASDAQ: XTLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTLB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XTLB stock methods without spending real money on the virtual paper trading platform.